Newsfeeds - Spark Newswire

1 minute read

FedEx Faces Price Target Cut By This Analyst; Also Check Out Some Other Major PT Changes

Today, 10:10 PM

Citigroup cut the price target on FedEx Corporation (NYSE: FDX) from $270 to $225. Citigroup analyst Christian Wetherbee also downgraded the stock from Buy to Neutral. FedEx shares fell 3% to trade at $202.52 on Tuesday.

AQST

1 minute read

HC Wainwright & Co. Maintains Buy on Aquestive Therapeutics, Lowers Price Target to $5

By Benzinga Newsdesk

Today, 10:10 PM

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Aquestive Therapeutics (NASDAQ:AQST) with a Buy and lowers the price target from $6 to $5.

AQST

4 minute read

Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 10:10 PM

Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in high-risk postoperative coronary artery bypass grafting patients.

ALLK

6 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 30, 2022

By Benzinga Insights

Today, 10:10 PM

AOUT

1 minute read

General

Aquestive Therapeutics On Aug 23, 2022 Co Received Notice From Nasdaq, Informing Co That It Regained Compliance With Nasdaq’s Listing Rule

By Bill Haddad

Today, 10:10 PM

-Reuters

AQST

8 minute read

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday

By Lisa Levin

Today, 10:10 PM

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

ACRX

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 10:10 PM

ALNA

1 minute read

Earnings

Aquestive Therapeutics: Q2 Earnings Insights

By Benzinga Insights

Today, 10:10 PM

Aquestive Therapeutics (NASDAQ:AQST) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Aquestive Therapeutics reported in-line EPS of $-0.36 versus an estimate of $-0.36.

AQST

17 minute read

Earnings Scheduled For August 2, 2022

By Benzinga Insights

Today, 10:10 PM

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

ABNB

1 minute read

Earnings

Earnings Preview: Aquestive Therapeutics

By Benzinga Insights

Today, 10:10 PM

Aquestive Therapeutics (NASDAQ:AQST) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Aquestive Therapeutics will report an earnings per share (EPS) of $-0.36.

AQST